Won Rare Denial of Class Certification for Medtronic in Securities Fraud Litigation

Defended Medtronic, Inc. and its officers and directors in a shareholder class action relating to Medtronic’s acquisition of Covidien PLC, an Irish entity, through an inversion. The plaintiffs alleged that structuring the transaction as an inversion caused them to incur significant capital gains taxes and diluted their corporate ownership. After we convinced the trial court to deny class certification and both the Minnesota Court of Appeals and Minnesota Supreme Court to deny review, the claims of the individual plaintiffs settled on favorable terms in 2021.